Illumina Inc (NASDAQ:ILMN) finished Wednesday with an addition of $4.39 to close at $133.30, an upside of 3.41 percent. An average of 1,899,240 shares of common stock have been traded in the last five days. There was a fall of -$5.05 in the past week, and it reached a new high 8 times over the past 12 months. The last 20 days have seen an average of 1,878,030 shares traded, while the 50-day average volume stands at 1,625,704.
ILMN stock has decreased by -15.74% in the last month. The company shares reached their 1-month lowest point of $127.37 on 09/26/23. With the stock rallying to its 52-week high on 03/13/23, shares of the company touched a low of $127.37 and a high of $248.87 in 52 weeks. It has reached a new high 8 times so far this year and lost -34.08% or -$68.90 in price. In spite of this, the price is down -46.44% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
ILMN stock investors should be aware that Illumina Inc (ILMN) stock had its last reported insider trading activity 37 days ago on Aug 22. In this transaction, the insider spent $83,520. SVP, Chief Commercial Officer, TOUSI SUSAN H, disposed of 500 shares at a price of $190.08 on Jul 24. The insider now owns more than $95,040 worth of shares. Prior to that, SVP, Chief Commercial Officer TOUSI SUSAN H went on to Sale 500 shares at $200.00 each on Jun 22. An amount of $100,000 was transacted.
Valuation Metrics
Illumina Inc (ILMN) stock’s beta is 1.17. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 4.73, the price-to-book (PB) ratio at 3.21.
Financial Health
The quick ratio of Illumina Inc for the three months ended June 29 was 1.13, and the current ratio was 1.40, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.34 and a total debt to equity ratio of 0.46 for the quarter ending June 29. Its gross profit as reported stood at $2.97 billion compared to revenue of $4.58 billion.
Earnings Surprise
For the three-month period that ended June 29, Illumina Inc had $1.49 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$234.0 million in the quarter, while revenues were shrunk -128.63%. The analyst consensus anticipated Illumina Inc’s latest quarter earnings to come in at $0.02 per share, but it turned out to be $0.32, a 1,500.00% surprise. For the quarter, EBITDA amounted to $20.0 million. Shareholders own equity worth $158.3 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Illumina Inc (ILMN) price momentum. RSI 9-day as of the close on 27 September was 25.64%, suggesting the stock is oversold, with historical volatility in this time frame at 28.21%.
As of today, ILMN’s price is $131.88 -3.65% or -$5.05 from its 5-day moving average. ILMN is currently trading -17.68% lower than its 20-day SMA and -32.09% lower than its 100-day SMA. However, the stock’s current price level is -26.08% below the SMA50 and -36.65% below the SMA200.
The stochastic %K and %D were 8.98% and 5.13%, respectively, and the average true range (ATR) was 4.60. With the 14-day stochastic at 17.05% and the average true range at 4.80, the RSI (14) stands at 24.71%. The stock has reached -5.11 on the 9-day MACD Oscillator while the 14-day reading was at -11.05.
Analyst Ratings
The consensus rating for Illumina Inc (ILMN) among analysts is Hold. According to current brokerage recommendations, 3 brokerage firms advise that investors sell ILMN, while 9 suggest investors hold. There are 1 analyst who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 8 others rate it as a “buy”.
What is ILMN’s price target for the next 12 months?
Analysts predict a range of price targets between $111.00 and $318.00, with a median target of $205.00. Taking a look at these predictions, the average price target given by analysts for Illumina Inc (ILMN) stock is $207.77.
